1988
DOI: 10.1016/0028-3908(88)90141-4
|View full text |Cite
|
Sign up to set email alerts
|

Comparative binding of μ and δ selective ligands in whole brain and pons/medulla homogenates from rat: Affinity profiles of fentanyl derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
1

Year Published

1990
1990
2009
2009

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(20 citation statements)
references
References 14 publications
2
17
1
Order By: Relevance
“…Alfentanil is a p-opioid agonist with a p/! selectivity ratio of over 600 in binding studies (Yeadon & Kitchen, 1988) and exhibits a profile in nociceptive tests consistent with p-receptor activation (Niemegeers & Janssen, 1981;Williams et al, 1982). Antinociception induced by alfentanil was blocked by naloxone and only slightly antagonized by naltrindole in doses up to 1 mgkg-' suggesting that naltrindole at these doses, in vivo, has negligible activity at "-receptors.…”
Section: Discussionmentioning
confidence: 84%
“…Alfentanil is a p-opioid agonist with a p/! selectivity ratio of over 600 in binding studies (Yeadon & Kitchen, 1988) and exhibits a profile in nociceptive tests consistent with p-receptor activation (Niemegeers & Janssen, 1981;Williams et al, 1982). Antinociception induced by alfentanil was blocked by naloxone and only slightly antagonized by naltrindole in doses up to 1 mgkg-' suggesting that naltrindole at these doses, in vivo, has negligible activity at "-receptors.…”
Section: Discussionmentioning
confidence: 84%
“…]deltorphin I or II (Erspamer et al, 1989), SNC80 (Bilsky et al, 1995) U69593 (Lahti et al, 1985), CI977 (Hunter et al, 1990), Salvinorin A (Roth et al, 2002) Endomorphin-1 and -2 (Zadina et al, 1997), morphine (Goldstein and Naidu, 1989), DAMGO (Handa et al, 1981), sufentanil (Yeadon and Kitchen, 1988), PL017 (Costa et al, 1992) N/OFQ, N/OFQ-(1-13)-NH 2 (Guerrini et al, 1997), Ro646198 (Jenck et al, 2000), UFP-112 (Rizzi et al, 2007) Selective antagonists Naltrindole (Portoghese et al, 1988), naltriben (Sofuoglu et al, 1991) Nor-binaltorphimine (Portoghese et al, 1987), GNTI (Stevens et al, 2000) CTAP (Pelton et al, 1986) …”
Section: Citation Informationmentioning
confidence: 99%
“…Selective agonists DPDPE (Mosberg et al, 1983), DSBULET (Delay-Goyet et al, 1988), [DAla 2 ]deltorphin I or II (Erspamer et al, 1989), SNC80 (Bilsky et al, 1995) U69593 (Lahti et al, 1985), CI977 (Hunter et al, 1990), Salvinorin A (Roth et al, 2002) Endomorphin-1 and 2 (Zadina et al, 1997), morphine (Goldstein and Naidu, 1989), DAMGO (Handa et al, 1981), sufentanil (Yeadon and Kitchen, 1988), PL017 (Costa et al, 1992) N/OFQ, N/OFQ-(1-13)-NH2 (Guerrini et al, 1997), Ro646198 (Jenck et al, 2000), UFP112 (Rizzi et al, 2007) Selective antagonists Naltrindole (Portoghese et al, 1988), naltriben (Sofuoglu et al, 1991) Nor-binaltorphimine (Portoghese et al, 1987), GNTI (Stevens et al, 2000) CTAP (Pelton et al, 1986) J113397 (8. 3, Kawamoto et al, 1999) (Hawkins et al, 1987) [ 3 H]-N/OFQ (Dooley and Houghten, 1996), Subtypes of m (m1, m2), d (d1, d2) and k (k1, k2, k3) receptor have been proposed based primarily on binding studies with poorly selective ligands or results from in vivo studies.…”
Section: Opioid and Opioid-like Bph_501_46 7879mentioning
confidence: 99%